Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder

As reported by financialpost.com

Article content This press release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws, includ...

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on financialpost.com ↗

Market Samachar is a news aggregator. This article was originally published by financialpost.com. Tap the button above to read the full story on their site.

INDIAN Sebi launches Demat 2.0 pilot for tokenised corporate bonds using DLT Share Market Today
INDIAN Mid-, smallcap rush lifts equity MF inflows to four-month high in August Share Market Today
INDIAN CAS faced initial liquidity issues across global markets: Sebi chairman Share Market Today
INDIAN US stocks today: US stocks open lower after hotter-than-expected producer inflation data Markets-Economic Times
COMPANIES Citi launches eFPI to cut foreign investor registration time in India to 5 days Stocks-Markets-Economic Times
INDIAN Canara Bank plans to raise Rs 4,500 crore through AT-1 bonds next week Markets-Economic Times
INDIAN Wall Street slumps as Brent crude climbs above $105, wholesale inflation rises mint - markets
INDIAN 'Buy' Nephrocare Health Services for 16% upside, says ICICI Securities; check share price target mint - markets

Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder

More from Market Samachar